Kim MY - Search Results

1

Cancer epigenetics: Past, present and future.

Lee JE, Kim MY. Lee JE, et al. Among authors: kim my. Semin Cancer Biol. 2022 Aug;83:4-14. doi: 10.1016/j.semcancer.2021.03.025. Epub 2021 Mar 31. Semin Cancer Biol. 2022. PMID: 33798724 Review.

2

Epigenetics: an emerging player in gastric cancer.

Kang C, Song JJ, Lee J, Kim MY. Kang C, et al. Among authors: kim my. World J Gastroenterol. 2014 Jun 7;20(21):6433-47. doi: 10.3748/wjg.v20.i21.6433. World J Gastroenterol. 2014. PMID: 24914365 Free PMC article. Review.

3

H3K27 Demethylase JMJD3 Employs the NF-κB and BMP Signaling Pathways to Modulate the Tumor Microenvironment and Promote Melanoma Progression and Metastasis.

Park WY, Hong BJ, Lee J, Choi C, Kim MY. Park WY, et al. Among authors: kim my. Cancer Res. 2016 Jan 1;76(1):161-70. doi: 10.1158/0008-5472.CAN-15-0536. Cancer Res. 2016. PMID: 26729791

4

Oncogenic KRAS Sensitizes Lung Adenocarcinoma to GSK-J4-Induced Metabolic and Oxidative Stress.

Hong BJ, Park WY, Kim HR, Moon JW, Lee HY, Park JH, Kim SK, Oh Y, Roe JS, Kim MY. Hong BJ, et al. Among authors: kim sk, kim hr, kim my. Cancer Res. 2019 Nov 15;79(22):5849-5859. doi: 10.1158/0008-5472.CAN-18-3511. Epub 2019 Sep 10. Cancer Res. 2019. PMID: 31506334

5

GALNT3 suppresses lung cancer by inhibiting myeloid-derived suppressor cell infiltration and angiogenesis in a TNFR and c-MET pathway-dependent manner.

Park MS, Yang AY, Lee JE, Kim SK, Roe JS, Park MS, Oh MJ, An HJ, Kim MY. Park MS, et al. Among authors: kim sk, kim my. Cancer Lett. 2021 Aug 17;521:294-307. doi: 10.1016/j.canlet.2021.08.015. Online ahead of print. Cancer Lett. 2021. PMID: 34416337

6

Role of GALNT14 in lung metastasis of breast cancer.

Kim MY. Kim MY. BMB Rep. 2017 May;50(5):233-234. doi: 10.5483/bmbrep.2017.50.5.055. BMB Rep. 2017. PMID: 28347399 Free PMC article.

7

c-MYC Drives Breast Cancer Metastasis to the Brain, but Promotes Synthetic Lethality with TRAIL.

Lee HY, Cha J, Kim SK, Park JH, Song KH, Kim P, Kim MY. Lee HY, et al. Among authors: kim sk, kim p, kim my. Mol Cancer Res. 2019 Feb;17(2):544-554. doi: 10.1158/1541-7786.MCR-18-0630. Epub 2018 Sep 28. Mol Cancer Res. 2019. PMID: 30266755

8

Synergistic triad epistasis of epigenetic H3K27me modifier genes, EZH2, KDM6A, and KDM6B, in gastric cancer susceptibility.

Lee SW, Park DY, Kim MY, Kang C. Lee SW, et al. Among authors: kim my. Gastric Cancer. 2019 May;22(3):640-644. doi: 10.1007/s10120-018-0888-9. Epub 2018 Oct 29. Gastric Cancer. 2019. PMID: 30374835

9

PARP1 and PRC2 double deficiency promotes BRCA-proficient breast cancer growth by modification of the tumor microenvironment.

Yang AY, Choi EB, So Park M, Kim SK, Park MS, Kim MY. Yang AY, et al. Among authors: kim sk, kim my. FEBS J. 2021 May;288(9):2888-2910. doi: 10.1111/febs.15636. Epub 2020 Dec 2. FEBS J. 2021. PMID: 33205541 Free article.

10

Systematic identification of a synthetic lethal interaction in brain-metastatic lung adenocarcinoma.

Moon JW, Hong BJ, Kim SK, Park MS, Lee H, Lee J, Kim MY. Moon JW, et al. Among authors: kim sk, kim my. Cancer Lett. 2024 Apr 28;588:216781. doi: 10.1016/j.canlet.2024.216781. Epub 2024 Mar 15. Cancer Lett. 2024. PMID: 38494150

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,203 results

Search Page